Cytokinetics Inc. buy Wells Fargo & Company
Start price
07.05.26
/
50%
€63.48
Target price
07.05.27
€89.31
Performance (%)
7.91%
Price
29.07.26
€68.50
Summary
This prediction is currently active. With a performance of 7.91%, the BUY prediction by Wells_Fargo___Compan for Cytokinetics Inc. is trending in the right direction. This prediction currently runs until 07.05.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | -1.912% | -1.912% |
| iShares Core DAX® | 1.717% | 3.368% |
| iShares Nasdaq 100 | -4.565% | -4.238% |
| iShares Nikkei 225® | -7.120% | -11.869% |
| iShares S&P 500 | -0.894% | 1.687% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (CYTK) had its price target raised by Wells Fargo & Company from $95.00 to $105.00. They now have an "overweight" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€55.40
10.04.26
10.04.26
€81.26
10.04.27
10.04.27
23.65%
29.07.26
29.07.26
